Featured White Papers
- PCI DSS therapy for the smaller retailer (McAfee)
- Oct. 14th: Simplified IT with Software-as-a-Service (SaaS) (ZDNet)
- The rise of Web commuting (Citrix Online)
MOBIC® - Brief Article
Accent on Living, Summer, 2000
A new option for people with osteoarthritis. MOBIC(R)(meloxicam) tablets have been approved by the U.S. Food and Drug Administration as a treatment for osteoarthritis. This is the third new non-steroidal antiinflammatory drug introduced to the market in the past two years. Osteoarthritis affects 80 percent of Americans over age 65.
COPYRIGHT 2000 Cheever Publishing, Inc.
COPYRIGHT 2001 Gale Group